Thyroid disease

Age-Specific Reference Intervals for Thyroid-Stimulating Hormones and Free Thyroxine to Optimize Diagnosis of Thyroid Disease

ThyroidPublished Cross-sectional study

Authors' conclusion

This study stressed the known importance of using age-specific RIs for TSH and FT4 in children. This study also showed the clinical relevance of using age-specific RIs for TSH in adulthood to reduce diagnoses of subclinical hypothyroidism in older persons.

Study context

Population
Thyroid-stimulating hormone (TSH) and free thyroxine (FT4) requests, 13 Dutch laboratories for general practitioners and local hospitals, 2008–2022; ages 2 to 100 years7.6 million TSH, 2.2 million FT4 requests
Outcome
Age-specific RIs for TSH and FT4 throughout life, and reclassification of thyroid disease diagnoses in adults
Methodological detailsmulticenter, retrospective, indirect reference intervals from big data, four immunoassay platforms
  • Multicenter
  • Retrospective
  • Indirect reference intervals from big data
  • Four immunoassay platforms

Main finding

As reported in the abstract

  • TSH upper reference limits and FT4 lower reference limits were higher in early childhood and decreased toward adulthood
  • In adulthood, TSH upper reference limits increased from 60 years in men and from 50 years in women
  • FT4 upper reference limits increased from 70 years onward
  • Reference interval (RIs) evaluated per manufacturer

Observational data: associations, not effects.

Further findings

Reclassification of diagnoses using adult age-specific RIs

Decrease in diagnoses of subclinical and overt hypothyroidism in women above 50 and men above 60 years (Roche dataset)

Original publication

Age-Specific Reference Intervals for Thyroid-Stimulating Hormones and Free Thyroxine to Optimize Diagnosis of Thyroid Disease. Thyroid. Published 30 September 2024. doi:10.1089/thy.2024.0346

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.